New HIV combo shot shows promise in early trial
NCT ID NCT05996471
First seen Jan 11, 2026 · Last updated May 07, 2026 · Updated 13 times
Summary
This study tests a new drug combination (VH3810109 plus cabotegravir) for adults with HIV whose virus is already well-controlled by standard medication. The goal is to see if this new approach can keep the virus suppressed as effectively as current treatments. About 185 participants will receive either the new combination or standard care, and researchers will monitor viral levels and side effects over six months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Birmingham, Alabama, 35222, United States
-
GSK Investigational Site
Bakersfield, California, 93301, United States
-
GSK Investigational Site
Los Angeles, California, 90027, United States
-
GSK Investigational Site
Los Angeles, California, 90069, United States
-
GSK Investigational Site
Palm Springs, California, 92262, United States
-
GSK Investigational Site
Sacramento, California, 95825, United States
-
GSK Investigational Site
San Francisco, California, 94110, United States
-
GSK Investigational Site
New Haven, Connecticut, 06510, United States
-
GSK Investigational Site
Washington D.C., District of Columbia, 20007, United States
-
GSK Investigational Site
Washington D.C., District of Columbia, 20037, United States
-
GSK Investigational Site
Fort Lauderdale, Florida, 33308, United States
-
GSK Investigational Site
Ft. Pierce, Florida, 34982, United States
-
GSK Investigational Site
Miami, Florida, 33133, United States
-
GSK Investigational Site
Orlando, Florida, 32803, United States
-
GSK Investigational Site
Pensacola, Florida, 32503, United States
-
GSK Investigational Site
Sarasota, Florida, 34237, United States
-
GSK Investigational Site
Vero Beach, Florida, 32960, United States
-
GSK Investigational Site
West Palm Beach, Florida, 33409, United States
-
GSK Investigational Site
Decatur, Georgia, 30033, United States
-
GSK Investigational Site
Chicago, Illinois, 60611, United States
-
GSK Investigational Site
Boston, Massachusetts, 02115, United States
-
GSK Investigational Site
Springfield, Massachusetts, 01105, United States
-
GSK Investigational Site
Southfield, Michigan, 48075, United States
-
GSK Investigational Site
Columbia, Missouri, 65212, United States
-
GSK Investigational Site
Newark, New Jersey, 07102, United States
-
GSK Investigational Site
Albuquerque, New Mexico, 87109, United States
-
GSK Investigational Site
Santa Fe, New Mexico, 87505, United States
-
GSK Investigational Site
Manhasset, New York, 11030, United States
-
GSK Investigational Site
New York, New York, 10029, United States
-
GSK Investigational Site
New York, New York, 10032, United States
-
GSK Investigational Site
New York, New York, 10461, United States
-
GSK Investigational Site
The Bronx, New York, 10467, United States
-
GSK Investigational Site
Greensboro, North Carolina, 27401-1209, United States
-
GSK Investigational Site
Cincinnati, Ohio, 45267, United States
-
GSK Investigational Site
Portland, Oregon, 97239, United States
-
GSK Investigational Site
Philadelphia, Pennsylvania, 19104, United States
-
GSK Investigational Site
Nashville, Tennessee, 37208, United States
-
GSK Investigational Site
Austin, Texas, 78705, United States
-
GSK Investigational Site
Dallas, Texas, 75246, United States
-
GSK Investigational Site
El Paso, Texas, 79902, United States
-
GSK Investigational Site
Houston, Texas, 77030, United States
-
GSK Investigational Site
Houston, Texas, 77098, United States
-
GSK Investigational Site
Watertown, Wisconsin, 53226, United States
-
GSK Investigational Site
San Juan, 00909, Puerto Rico
-
GSK Investigational Site
San Juan, 909, Puerto Rico
Conditions
Explore the condition pages connected to this study.